1990-2015年全球高血压及收缩压至少110至115 mm Hg的疾病负担
该研究为比较风险评估,基于154个国家844项研究、869万参与者的收缩压分布数据,采用时空高斯过程回归估计1990-2015年195个国家和地区的平均收缩压及相关疾病负担。结果显示,收缩压≥110-115 mm Hg的率从73 119/10万增至81 373/10万,≥140 mm Hg的率从17 307/10万增至20 526/10万;相关年死亡率分别从135.6/10万增至145.2/10万、从97.9/10万增至106.3/10万。≥140 mm Hg相关DALYs从95.9百万增至143.0百万(原文此处标注[corrected]),≥140 mm Hg相关DALYs从5.2百万增至7.8百万。相关死亡数最多者为缺血性心脏病(4.9百万,54.5%)、出血性卒中(2.0百万,58.3%)和缺血性卒中(1.5百万,50.0%)。2015年中国、印度、俄罗斯、印度尼西亚和美国占全球收缩压≥110-115 mm Hg相关DALYs的一半以上。
要点
- 1990-2015年收缩压≥110-115 mm Hg的率从73 119/10万增至81 373/10万,≥140 mm Hg的率从17 307/10万增至20 526/10万。
- 收缩压≥110-115 mm Hg相关年死亡率从135.6/10万增至145.2/10万,≥140 mm Hg相关年死亡率从97.9/10万增至106.3/10万。
- 收缩压≥140 mm Hg相关DALYs从95.9百万增至143.0百万(原文标注[corrected]),≥140 mm Hg相关DALYs从5.2百万增至7.8百万。
- 收缩压相关死亡数最多者为缺血性心脏病(4.9百万,54.5%)、出血性卒中(2.0百万,58.3%)和缺血性卒中(1.5百万,50.0%)。
- 2015年估计35亿成人收缩压≥110-115 mm Hg、8.74亿成人收缩压≥140 mm Hg;中国、印度、俄罗斯、印度尼西亚和美国占全球≥110-115 mm Hg相关DALYs一半以上。
适用人群与场景
- 195个国家和地区的成人,按年龄、性别、国家、年份分析,1990-2015年。
研究设计与关键结果
- 研究类型为比较风险评估,基于154个国家844项研究(1980-2015年发表)、869万参与者的收缩压分布数据,采用时空高斯过程回归估计各年龄、性别、国家、年份的平均收缩压和校正方差。
- 主要分析纳入有充分证据支持与高收缩压存在因果关系的疾病(如缺血性心脏病、缺血性卒中和出血性卒中)。
- 1990-2015年收缩压≥110-115 mm Hg的率从73 119/10万(95% UI 67 949-78 241)增至81 373/10万(95% UI 76 814-85 770);≥140 mm Hg的率从17 307/10万(95% UI 17 117-17 492)增至20 526/10万(95% UI 20 283-20 746)。
- 收缩压≥110-115 mm Hg相关年死亡率从135.6/10万(95% UI 122.4-148.1)增至145.2/10万(95% UI 130.3-159.9);≥140 mm Hg相关年死亡率从97.9/10万(95% UI 87.5-108.1)增至106.3/10万(95% UI 94.6-118.1)。
- 收缩压≥140 mm Hg相关DALYs从95.9百万(95% UI 87.0-104.9百万)增至143.0百万(95% UI 130.2-157.0百万)[corrected];≥140 mm Hg相关DALYs从5.2百万(95% UI 4.6-5.7百万)增至7.8百万(95% UI 7.0-8.7百万)。
- 收缩压相关死亡数最多者为缺血性心脏病(4.9百万[95% UI 4.0-5.7百万];54.5%)、出血性卒中(2.0百万[95% UI 1.6-2.3百万];58.3%)和缺血性卒中(1.5百万[95% UI 1.2-1.8百万];50.0%)。
- 2015年中国、印度、俄罗斯、印度尼西亚和美国占全球收缩压≥110-115 mm Hg相关DALYs的一半以上;基于该样本的预测估计2015年35亿成人收缩压≥110-115 mm Hg、8.74亿成人收缩压≥140 mm Hg。
证据类型、等级与局限
- 证据类型为比较风险评估(基于844项研究的建模分析)。
- 原文指出部分估计存在不确定性。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Elevated systolic blood (SBP) pressure is a leading global health risk. Quantifying the levels of SBP is important to guide prevention policies and interventions.
OBJECTIVE: To estimate the association between SBP of at least 110 to 115 mm Hg and SBP of 140 mm Hg or higher and the burden of different causes of death and disability by age and sex for 195 countries and territories, 1990-2015.
DESIGN: A comparative risk assessment of health loss related to SBP. Estimated distribution of SBP was based on 844 studies from 154 countries (published 1980-2015) of 8.69 million participants. Spatiotemporal Gaussian process regression was used to generate estimates of mean SBP and adjusted variance for each age, sex, country, and year. Diseases with sufficient evidence for a causal relationship with high SBP (eg, ischemic heart disease, ischemic stroke, and hemorrhagic stroke) were included in the primary analysis.
MAIN OUTCOMES AND MEASURES: Mean SBP level, cause-specific deaths, and health burden related to SBP (≥110-115 mm Hg and also ≥140 mm Hg) by age, sex, country, and year.
RESULTS: Between 1990-2015, the rate of SBP of at least 110 to 115 mm Hg increased from 73 119 (95% uncertainty interval [UI], 67 949-78 241) to 81 373 (95% UI, 76 814-85 770) per 100 000, and SBP of 140 mm Hg or higher increased from 17 307 (95% UI, 17 117-17 492) to 20 526 (95% UI, 20 283-20 746) per 100 000. The estimated annual death rate per 100 000 associated with SBP of at least 110 to 115 mm Hg increased from 135.6 (95% UI, 122.4-148.1) to 145.2 (95% UI 130.3-159.9) and the rate for SBP of 140 mm Hg or higher increased from 97.9 (95% UI, 87.5-108.1) to 106.3 (95% UI, 94.6-118.1). For loss of DALYs associated with systolic blood pressure of 140 mm Hg or higher, the loss increased from 95.9 million (95% uncertainty interval [UI], 87.0-104.9 million) to 143.0 million (95% UI, 130.2-157.0 million) [corrected], and for SBP of 140 mm Hg or higher, the loss increased from 5.2 million (95% UI, 4.6-5.7 million) to 7.8 million (95% UI, 7.0-8.7 million). The largest numbers of SBP-related deaths were caused by ischemic heart disease (4.9 million [95% UI, 4.0-5.7 million]; 54.5%), hemorrhagic stroke (2.0 million [95% UI, 1.6-2.3 million]; 58.3%), and ischemic stroke (1.5 million [95% UI, 1.2-1.8 million]; 50.0%). In 2015, China, India, Russia, Indonesia, and the United States accounted for more than half of the global DALYs related to SBP of at least 110 to 115 mm Hg.
CONCLUSIONS AND RELEVANCE: In international surveys, although there is uncertainty in some estimates, the rate of elevated SBP (≥110-115 and ≥140 mm Hg) increased substantially between 1990 and 2015, and DALYs and deaths associated with elevated SBP also increased. Projections based on this sample suggest that in 2015, an estimated 3.5 billion adults had SBP of at least 110 to 115 mm Hg and 874 million adults had SBP of 140 mm Hg or higher.
参考来源
- Forouzanfar MH, Liu P, Roth GA, et al. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015. JAMA. 2017. PMID: 28097354. doi:10.1001/jama.2016.19043
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。